The World Economic Forum took place this week in Davos, Switzerland, where a collection of CEOs from the leading biopharmaceutical companies, the World Bank and the Union for International Cancer Control (UICC) announced a global initiative to address the rise of Non-Communicable Diseases (NCD) in low and lower-middle income countries.
The initiative, called Access Accelerated a first-of-its-kind collaboration focused on improving care for NCDs, was an integrated effort across three of our agencies. McCann Global Health led the communications strategy, creative branding assets and voice, working in conjunction with Consulting at McCann Health who led the industry strategy. Weber Shandwick led the PR effort, the launch event in Davos as well as the continuing social media outreach. MRM//McCann built the Access Accelerated website.
This type of integrated exposure to the CEOs of the top 18 global pharma companies boosts our reputation and plays true to our capabilities of being a truly networked network.
At the event about 70 people joined the discussion with leading pharma CEOs Olivier Brandicourt, Sanofi; Tim Evans, World Bank Group; Cary Adams, UICC; Stefan Oschmann, Merck; and Ian Read, Pfizer. Remarks from guests Sania Nishtar, Heartfile, Pakistan; Mati Gill, Teva; and Francis Collins, National Institutes of Health, reinforced enthusiasm for the initiative, potential new partnerships and connections to progress the work further.
We are very proud to have McCann Global Health, Weber Shandwick and MRM//McCann playing such an integral leadership role in this important initiative as NCDs have become a global problem effecting countries, communities and citizens throughout the world.